PRESS RELEASE
27 January 2025

IndusLaw Deal Report - Piramal Alternatives And 3Gen Consulting

I
IndusLaw

Contributor

INDUSLAW is a multi-speciality Indian law firm, advising a wide range of international and domestic clients from Fortune 500 companies to start-ups, and government and regulatory bodies.
We advised Piramal Alternatives and 3Gen Consulting and its promoters on Piramal Alternatives investment of USD 21.8 million in 3Gen Consulting.
India

Piramal Alternatives invests approx. USD 21.8 million in 3Gen Consulting Services Private Limited (3 Gen Consulting)

Piramal Alternatives is the fund management business of the Piramal Group. Piramal Alternatives invested in 3 Gen Consulting through Piramal Alternatives India Credit Opportunities Fund II.

3 Gen Consulting is a healthcare consulting and revenue cycle management (RCM) provider with presence in India and the US.

Our firm advised Piramal Alternatives and 3Gen Consulting and its promoters on this transaction.

INDUSLAW Team:

Piramal Alternatices Fund: Ashutosh Narang (Partner), Nitika Jain (Partner), Naman Jain (Associate), Sai Akanksh Deekonda (Associate) and Manohar Singh (Associate).

3Gen Consulting: Shantanu Jindel (Partner), Shweta Gupta (Partner), Harshit Kumar (Senior Associate) and Vatsal Agarwal (Associate).

1. https://www.thehindubusinessline.com/companies/piramal-alternatives-fund-to-invest-185-crore-in-3genconsulting/article68981769.ece;

2. https://economictimes.indiatimes.com/news/india/piramal-alternatives-lines-up-185-cr-for-3genconsulting/articleshow/116263152.cms?from=mdr;

3. https://www.biospectrumindia.com/news/86/25452/piramal-alternatives-fund-invests-rs-185-cr-in-healthcare-provider-3genconsulting-.html

Contributor

INDUSLAW is a multi-speciality Indian law firm, advising a wide range of international and domestic clients from Fortune 500 companies to start-ups, and government and regulatory bodies.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More